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Background: Aging is an inevitable biological process characterized by a general decline in various
physiological functions and resistance to stress. The aim of the present study was to investigate the
effects of taurine on advanced oxidation protein products, malondialdehyde, glutathione, and superoxide
dismutase, in young and middle-aged rat cerebellum.
Materials and methods: Middle-aged (13e14 months of age) male albino Wistar rats were divided into
two groups as the middle-aged control and the middle-aged taurine groups. Young (6e7 weeks of age)
male albino Wistar rats were divided into two groups as the young control and the young taurine groups.
While the rats in the control groups were given 0.5 mL of isotonic sodium chloride, the others were given
taurine by intraperitoneal injection at a single dose of 200 mg/kg/day for 7 days.
Results: The cerebellum glutathione levels were signiﬁcantly higher in the control group of young rats
when compared to the control group of middle-aged rats (p< 0.05). The cerebellum malondialdehyde
levels were signiﬁcantly lower in the taurine group ofmiddle-aged rats when compared to themiddle-aged
control (p< 0.05). The cerebellum glutathione levels were increased in the taurine group of middle-aged
rats when compared to the middle-aged control group (p< 0.05). The cerebellum malondialdehyde
levels were signiﬁcantly lower in the young taurine group when compared to the young control (p< 0.05).
Conclusion: In conclusion, the results of the present study suggest that exogenous taurine can prevent the
increased production of age-related lipid peroxidation products and might have a potential role for the
retardation of age-related oxidative events.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Aging is the accumulation of changes which increase the risk of
mortality. Environmental and genetic factors and disease are the
causes of aging. Furthermore, oxidant and antioxidant status may
also cause the degenerative changes encountered in aging. Oxida-
tive stress is proposed as a key element in the aging process1.
Several theories have been proposed to explain the mechanisms
involved in the pathogenesis of neurodegenerative diseases.
Oxidative stress is one of the widely accepted theories to explain
the pathogenesis of senescence-related diseases2.
The brain consumes almost 20% of the total oxygen inspired.
Presence of polyansaturated fatty acids (PUFAs) in high levels serve
as an important target for the reactive oxygen species3. Variable
metabolic rates in different regions of the central nervous systemerest.
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irim).
iwan Society of Geriatric Emergencan lead to the region-speciﬁc accumulation of oxidative damage
andmake the speciﬁc regions of the brain vulnerable to senescence
related disorders4. The effects of aging in various parts of the
central nervous system differ greatly5,6. It is widely accepted that
oxidative stress increases in the brain during aging7.
The role of increased oxidative stress in the development of
oxidative protein damage in aging is currently a subject of great
interest8e10. It was previously reported that both skeletal muscle
aging and brain aging are associated with an increase in oxidatively
modiﬁed amino acids8e10.
Protein oxidation is currently considered to be an important
factor in a variety of disorders such as Alzheimer’s and Parkinson’s
disease, cancer, hypertension, cardiovascular diseases, diabetes,
ischemia-reperfusion injury and aging11e13. Many different types of
oxidative protein modiﬁcations can be induced directly by reactive
oxygen species (ROS) or indirectly by reactions of secondary by-
products of oxidative stress14.
A new type of marker of protein oxidation, namely advanced
oxidation protein products (AOPPs), has been the subject of recent
studies. AOPPs are described as dityrosine-containing cross-linkedcy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
The cerebellum advanced oxidation protein product, malondialdehyde, glutathione
levels and superoxide dismutase activities in young and middle-aged rats control
and young and middle-aged rats taurine groups (a single dose of 200 mg/kg/day for
7 days).
Young control,
mean SD
(n ¼ 10)
Young taurine,
mean SD
(n ¼ 10)
Middle-aged
control,
mean SD
(n ¼ 10)
Middle-aged
taurine,
mean SD
(n ¼ 10)
AOPP
(nmol/mg
protein)
1.86 1.30 3.23 1.84 2.00 1.99 3.22 3.45
MDA
(nmol/g tissue)
10.31 1.33a 7.15 1.00a 9.43 1.64b 7.19 2.10b
GSH
(mmol/g tissue)
0.38 0.12c 0.91 0.21 0.70 0.13c,d 0.88 0.29d
SOD
(U/mg protein)
2.42 2.31 1.53 1.62 1.86 1.30 3.23 1.84
a MDA between the taurine group of young rats and the control group of young
rats (p< 0.05).
b MDA between the taurine group of middle-aged rats and the control group of
middle-aged rats (p< 0.05).
c GSH between the control group of middle-aged rats and the control group of
young rats (p< 0.05).
d GSH between the taurine group of middle-aged rats and the control group of
middle-aged rats (p< 0.05). AOPP ¼ advanced oxidation protein products; GSH ¼
glutathione; MDA ¼malondialdehyde; SD ¼ standard deviation; SOD ¼ superoxide
dismutase.
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protein aggregates that form as a result of disulphide links following
a subtle oxidative stress. Therefore, the presence of AOPPs may be
a good and more accurate marker of oxidative stress than lipid
peroxidation products15.
Lipid peroxidation leads to the damage of PUFAs in membrane
phospholipids16. Lipid peroxidation has an important role in tissue
injury. However, the exact role of lipid peroxidation products in the
aging of tissues is not clear. Malondialdehyde (MDA) is the most
abundant aldehyde resulting from lipid peroxidation. As a general
rule, tissue levels of free radicals, lipid peroxidation products, and
antioxidants show important changes from one tissue to another
with increasing age17.
Endogenous antioxidants such as non-enzymatic scavenger
glutathione (GSH) and antioxidant enzymes such as superoxide
dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT)
are the ﬁrst line of defense and act by scavenging potentially
damaging free radical moieties1.
Taurine is an ubiquitous sulfur-containing amino acid which is
normally present in high concentrations in mammalian plasma and
cells. It plays various important physiological functions including in
osmoregulation and bile acid conjugation, pharmacological actions,
pathological states and prevention of oxidant-induced injury in
many tissues18. The useful effects of taurine as an antioxidant in
biological systems have been attributed to its ability to stabilize
biomembranes, to scavenge ROS, and to decrease the peroxidation
of unsaturated membrane lipids19. In addition, taurine scavenges
hypochlorous acid produced by the activation of granulocytes,
forming taurine-chloramine, and thus may act as an indirect
antioxidant20.
Taurine is structurally similar to a number of other endogenous
substances, particularly glycine and gamma-aminobutyric acid and
is the second or thirdmost abundant amino acid within the brain of
vertebrates, present in millimolar concentrations in regions such as
the cerebellum and cerebral cortex21.
In this study, the effects of taurine supplementation on the
levels of AOPP, MDA, GSH, and on the activities of the antioxidant
enzyme, SOD, in the cerebellum of young and middle-aged Wistar
rats were investigated.
2. Materials and methods
2.1. Subjects
The present study was carried out according to the Gazi Univer-
sity Laboratory Animal Welfare and Ethical Committee regulations.
Twenty middle-aged (13e14 months of age) male albino Wistar
rats (400 20 g) were divided into two groups as the middle-aged
control and the middle-aged taurine groups. Twenty young (6e7
weeks of age) male albino Wistar rats (17010 g) were also
divided into two groups as the young control and the young taurine
groups. While the rats in the control groups were given 0.5 mL of
isotonic sodium chloride, the others were given taurine by intra-
peritoneal injection at a single dose of 200 mg/kg/day for 7 days22.
Anesthesia with sodium thiopental was performed 24 hours after
the last injection. The cerebellum was removed, washed in cold 9%
sodium chloride, wiped, weighed, and frozen in liquid nitrogen and
kept frozen at 70C until used.
The SOD activity measurements were carried out by inhibiting
the SOD activity by nitro blue tetrazolium reduction. Xanthine-
xanthine oxidase was used as a superoxide generator, and 1 IU was
deﬁned as the quantity of SOD required to produce 50% inhibition23.
Protein levels were determined by a spectrophotometric
method (Schimadzu UV 1601 spectrophotometer, Schimadzu Corp.,
Tokyo, Japan) using bovine serum albumin as the standard24.AOPP levels were measured by a spectrophotometric method
(Schimadzu UV 1601 spectrophotometer, Schimadzu Corp) in the
presence of potassium iodide at 340 nm15 and calibrated with
chloramine-T solutions. AOPP levels were expressed in micromoles
chloramine-T equivalents per liter.
Lipid peroxidation was quantiﬁed by measuring the formation
of thiobarbituric acid reactive substances (TBARS) test as
described previously25. The MDA concentration was calculated
from the absorption at 532 nm by use of a molar extinction
coefﬁcient of 1.56105 mol1 cm1, and also recalculated from
our MDA standards produced by the acid hydrolysis of 1,1,3,3-
tetramethoxypropane.
The GSH levels were determined by a modiﬁed Ellman
method26. Brieﬂy, after centrifugation and treating with sodium
phosphate dibasic dihydrate (Na2HPO4.2H2O), supernatants were
reacted with 5,5-dithiobis (2-nitrobenzoic acid). Absorbance was
read using the spectrophotometer at 412 nm. The GSH levels were
calculated using an extinction coefﬁcient of 13.000 mol1 cm1.
2.2. Statistical analysis
Data are presented as the mean standard deviation. Statistical
analyses were conducted by KruskalWallis test andMann-Whitney
U-test (SPSS for Windows 11.5; SPSS, Chicago, IL, USA). A value of
p< 0.05 was deﬁned as signiﬁcant.
3. Results
The cerebellum GSH levels were signiﬁcantly higher in the
young control group when compared to the middle-aged control
group (p< 0.05; Table 1). The cerebellum MDA levels were signif-
icantly lower in the middle-aged taurine group when compared to
the middle-aged control (p< 0.05; Table 1). The cerebellum GSH
levels were signiﬁcantly increased in the middle-aged taurine
group when compared to the middle-aged control group (p< 0.05;
Table 1). The cerebellumMDA levels were signiﬁcantly lower in the
young taurine group when compared to the young control group
(p< 0.05; Table 1). It was shown that, in the study groups, the
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7 days treatment with 200 mg/kg/day taurine (Table 1).
4. Discussion
Neurodegenerative disorders are widely known health prob-
lems for elderly people. Aging is considered as the major risk factor
in most neurodegenerative disorders3. Parkinson’s disease, Alz-
heimer’s disease, and stroke disease are the well-known examples
of age-related neurodegenerative disorders11.
Many researchers support the view that the oxidative status of
aged animals is elevated as compared with the young animals27e30.
However, the causes for this increased oxidative stress are not well
deﬁned. It has been previously shown that free radicals may be
seriously harmful to many cellular components such as DNA31,
proteins31e33, and lipids34.
Although lipid peroxidation products caused by free radicals
have been studied by many researchers regarding the different
anotomical areas of the brain34e36, few studies have looked into the
oxidative protein damage in the aging brain9,11,31,35,37.
AOPP measurements reﬂect the free radical generation and the
degree of protein oxidation15,38. It was demonstrated that the
skeletal muscle AOPP levels were signiﬁcantly increased in old rats
compared with those of the adult rats33. In addition, the liver AOPP
levels were higher in the control group of middle-aged rats when
compared to the control group of young rats. The liver AOPP levels
were decreased by the administration of taurine in middle-aged
rats. However, the difference between the taurine and control
groups was not signiﬁcant in the liver39. In the present study,
cerebellum AOPP levels did not change neither by age nor by
taurine supplementation. The results of the present study indicated
that taurine has no effect in reducing protein oxidation in the
cerebellum.
It was previously reported that both normal rodent brain aging
and normal human brain aging are associated with an increase in
oxidatively modiﬁed amino acids. These amino acids and their
derivatives are being used as markers to assess oxidative protein
damage37e40.
In the studies conducted on the rat model, increased lipid per-
oxidation and decreased antioxidant capacity has been reported in
the aged animals compared to the young ones41,42. On the contrary,
in some reports no change in the levels of oxidant stress and
antioxidant capacity has been reported43,44.
In the studies conducted on healthy people, MDA and other
oxidative stress indicators are higher in older people than
younger45,46. It was shown that lipid peroxidation products are
increased in old rat brain and liver homogenates as well as in old
human plasma45,47.
It has been demonstrated that aging is associated with statisti-
cally signiﬁcant increases in lipid peroxidation (including MDA and
4-hydroxyalkenals), 8-hydroxy-2-deoxyguanosine, and protein
carbonyls and a drop in membrane ﬂuidity in a variety of organs in
the experimental models7. An increase 8-oxodeoxyguanine levels
of the cerebellum and cerebral cortex has also been shown48.
There are few reports showing that TBARS levels do not change
with cerebral aging47, however others have shown an increase in
lipid peroxidation levels20,49. In addition, the level of antioxidant
enzyme activities have been reported to differ considerably in the
various brain regions50. It has been demonstrated that the cere-
bellum and frontal and occipital cortex MDA levels were signiﬁ-
cantly increased in old rats compared with those of the younger
and middle-aged rats51. In the present study, cerebellum MDA
levels did not change with age.
Taurine is a well known substance that has antioxidant prop-
erties in peroxidatively damaged tissues. MDA level, which is anindicator of lipid peroxidation, increases in taurine-deﬁcient rats52.
The possible peroxidation-preventing effect of taurine in the aging
process is observed in this study. After 7 days of treatment with
200 mg/kg/day of taurine, the cerebellum MDA level was signiﬁ-
cantly reduced in all rats. The results of this study indicated that
the MDA-reducing effect of taurine is more effective in younger
rats than older rats. In an earlier study, the rat liver MDA level
was signiﬁcantly reduced by age after 7 days treatment with
200 mg/kg/day taurine53.
In the literature, results indicating an increase or decrease or
even no change of the level of antioxidant enzyme activity in
several tissues with old age were reported. However, it is believed
that antioxidant defense is usually weakened in old age54,55. It was
previously reported that antioxidant functions decline in almost all
aged mammals17.
Antioxidant enzymes are considered to be a primary defense
system preventing biological macromolecules from oxidative
damage. SOD is a key antioxidant enzyme in the metabolism of
oxygen free radicals. SOD is mainly located in neurons whereas
GPx, the major protective enzyme against the action of hydrogen
peroxide, is mostly present in astrocytes. The brain has a much
higher SOD to GPx activity ratio than the other organs of rats56.
Many investigators have published studies on age-related
changes of brain total SOD activity in rodents, sometimes with
conﬂicting results. Brain SOD activities have been reported to be
unchanged as a result of aging in whole brain from older Wistar
rats57 and in older Fisher 344 rats58, although the SOD activity was
unaffected in several structures, namely the cerebellum, cortex,
hippocampus, hypothalamus and striatum, in Wistar rats59. Inter-
estingly, it has decreased in brain areas such as the cerebellum,
cortex, hippocampus and hypothalamus from Charles Faster rats60
and in whole brain from Fischer 344 rats61.
It has been demonstrated that SOD activity in the brain of mouse
and Mongolian gerbil increased with age31,62. It was also shown
that SOD activities in mitochondria and cytosol fractions of the
cortex, hippocampus, striatum, midbrain, pons and medulla
oblongata and cerebellum of aged rats increased compared with
those of adult rats63.
Taurine may also inhibit the lipid peroxidation by inducing GPx
and SOD. Taurine could protect tissues against GSH pool depletion
by preventing the decreases in GR activities54.
Pushpakiran et al64 showed the increase in the protective effect
of taurine against oxidative stress caused by ethanol. They found
that 28 days of taurine treatment lowers the TBARS in the brain,
liver, kidney, heart, and plasma. On the other hand, the decreased
activities of SOD, CAT and GPx with ethanol increased with taurine
supplementation.
In the present study, it was determined that the cerebellum
SOD activity did not change neither by age nor by taurine
supplementation.
Taurine is primarily synthesized in the liver and its synthesis
is determined by the availability of cysteine and methionine.
Taurine and GSH biosynthesis are closely related. Cysteine is also
a constituent of GSH. GSH is a major non-enzymic antioxidant that
is effective against free radicals65.
It has been demonstrated that the cerebellum and frontal and
occipital cortex GSH levels were signiﬁcantly decreased in old rats
compared with those of the younger and middle-aged rats51. These
results are in agreement with Sandhu and Kaur who observed
a similar decline in the level of GSH in aged rat brain66.
Signiﬁcant decreases in antioxidant levels were observed during
aging. The levels of GSH reduced by 60% in older rats (24e28
months)67. In this study, it was determined that cerebellum GSH
level was signiﬁcantly higher in the young control group when
compared to the middle-aged control group. The cerebellum GSH
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when compared to the control group. The cerebellum GSH level
was higher in the young taurine group when compared to the
control group. However the difference was not signiﬁcant.
Taurine has also been proposed as a neuromodulator and may
have additional roles such as neuroprotection from excitotoxic cell
death and regulation of protein phosphorylation. In addition, it has
been proposed that taurine plays a signiﬁcant role during brain
development, modulating the processes of neuronal differentia-
tion, migration, synaptogenesis and development21.
The brain synthesizes only a limited amount of taurine, with
most taurine synthesis occurring in the liver. Accordingly, irre-
spective of whether taurine is derived from diet or synthesized by
the liver, it is probable that signiﬁcant amounts of taurine will
require transport into the brain and than transport into those
cellular compartments that sequester this amino acid21.
It was demonstrated that the cerebellum taurine concentrations
were decreased in 9-month- and 26-month-old Fischer 344 rats. A
possible reason for this age-dependent decline in taurine levels
could be decreased biosynthesis65.
Nevertheless, experimental results strongly suggest that the
maintenanceof anappropriate antioxidant/pro-oxidantbalancedoes
have an important role in maintaining health in the aging animal.
The inhibitory amino acid taurine has been shown to play
a pivotal role in the development of the central nervous system and
in the survival of neurons. It protects neural cells from excitotox-
icity induced by excitatory amino acids in the cerebellum and
hippocampus68.
In conclusion, the results of this study suggest that exogenous
taurine may delay the aging process of tissues by means of its free
radical scavenging effects, and might have a potential role for the
retardation of age-related oxidative events.
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